Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:monoclonal_antibody
|
| gptkbp:associated_with |
gptkb:Guillain-Barré_syndrome
gptkb:Miller_Fisher_syndrome demyelinating diseases |
| gptkbp:can_be_found_in |
patients with GBS
patients with MFS |
| gptkbp:can_cause |
ataxia
ophthalmoplegia areflexia |
| gptkbp:can_detect |
gptkb:serum
gptkb:immunotherapy chronic inflammatory demyelinating polyneuropathy (CIDP) |
| gptkbp:can_lead_to |
muscle weakness
sensory loss reflex loss |
| gptkbp:diagnostic_marker_for |
gptkb:Miller_Fisher_syndrome
|
| https://www.w3.org/2000/01/rdf-schema#label |
anti-GQ1b antibodies
|
| gptkbp:involved_in |
neurological disorders
|
| gptkbp:is_analyzed_in |
Western blotting
immunofluorescence enzyme-linked immunosorbent assay (ELISA) |
| gptkbp:is_associated_with |
gptkb:depression
anxiety dizziness fatigue nausea sleep disturbances chronic pain vaccination vomiting respiratory failure diarrhea social withdrawal viral infections bacterial infections tremors cognitive dysfunction autonomic dysfunction visual disturbances erectile dysfunction neuropathic pain urinary retention sweating abnormalities dysautonomia temperature dysregulation post-infectious syndromes paresthesia quality of life impairment |
| gptkbp:is_studied_in |
clinical research
|
| gptkbp:measures |
CSF
|
| gptkbp:participated_in |
neuromuscular junction dysfunction
|
| gptkbp:produced_by |
B cells
|
| gptkbp:targeted_antigen |
gptkb:GQ1b_ganglioside
|
| gptkbp:treatment |
gptkb:immunotherapy
plasma exchange intravenous immunoglobulin (IVIG) |
| gptkbp:bfsParent |
gptkb:Miller_Fisher_syndrome
|
| gptkbp:bfsLayer |
7
|